Concepedia

Author

Toshiki Hatanaka

Astellas Pharma (Japan)

Also Known As

Toshiki Hatanaka

14

Publications

380

Citations

9

H-Index

9

Concepts

All Affiliations

Astellas Pharma (Japan)GlaxoSmithKline (Japan)
TH

About

Toshiki Hatanaka is an author at Astellas Pharma (Japan) specializing in physiology, medicine, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

235

2

Pharmacology

5

5

235

3

Molecular Pharmacology

4

4

118

4

Biochemistry

1

1

24

5

Drug Discovery

1

1

46

Toshiki Hatanaka

×

9

Publications

364

Citations

9

H-Index

YearCitations

In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats

Akiyoshi Ohtake, Masashi Ukai, Toshiki Hatanaka,

European Journal of Pharmacology

2004

117

Pharmacological Characterization of a New Antimuscarinic Agent, Solifenacin Succinate, in Comparison with Other Antimuscarinic Agents

Akiyoshi Ohtake, Chikashi Saitoh, Hironori Yuyama,

Biological and Pharmaceutical Bulletin

2007

72

In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe,

Naunyn-Schmiedeberg s Archives of Pharmacology

2012

46

Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe,

Naunyn-Schmiedeberg s Archives of Pharmacology

2012

34

The new radioligand [3H]-L 748,337 differentially labels human and rat β3-adrenoceptors

Jan–Peter van Wieringen, Martina B. Michel-Reher, Toshiki Hatanaka,

European Journal of Pharmacology

2013

24

Tamsulosin Potently and Selectively Antagonizes Human Recombinant .ALPHA.1A/1D-Adrenoceptors: Slow Dissociation from the .ALPHA.1A-Adrenoceptor May Account for Selectivity for .ALPHA.1A-Adrenoceptor over .ALPHA.1B-Adrenoceptor Subtype

Shuichi Sato, Toshiki Hatanaka, Hironori Yuyama,

Biological and Pharmaceutical Bulletin

2012

22

Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed‐dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator‐blind, parallel‐group study

Nobukazu Hayashi, Ichiro Kurokawa, Obukohwo Siakpere,

The Journal of Dermatology

2018

20

Understanding patient and physician perceptions of male androgenetic alopecia treatments in Asia–Pacific and Latin America

Zrinka Lulic, Shigeki Inui, Woo‐Young Sim,

The Journal of Dermatology

2017

15

Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys

Toshiki Hatanaka, Masashi Ukai, Mai Watanabe,

Naunyn-Schmiedeberg s Archives of Pharmacology

2013

14

Page 1